VEGFC and urinary bladder cancer: Their findings demonstrate how miR-122 controlled cell proliferation via the VEGFC/AKT/mTOR signaling cascade, and they suggest that exogenous miR-122 overexpression may be a feasible method for targeted bladder cancer treatments [45].